Sanford Burnham
  • Sanford Burnham
  • Twitter
  • Facebook
  • Youtube
  • Navigate Sanford-Burnham
    • Main Site
    • Our Mission
    • Research
    • Talent
    • Technology
    • Training & Education
    • Our Supporters
    • News

Beaker

Sanford-Burnham Science Blog

Subscribe

Food, energy, and orexin

by Josh Baxt on July 2, 2010 at 2:47 pm | 8 Comments

Ever wonder why you feel sleepy after a heavy meal and why it is difficult to catch some Zs when you’re hungry? It’s because our blood glucose levels directly control the amount of a hormone called orexin, which influences hunger and sleep/wake cycles. High glucose after a meal reduces orexin levels and the activity of orexin-producing neurons, making us feel sluggish. Plunging glucose levels following overnight fasting elevates orexin levels, which wakes us up to seek food. In other words, soaring orexin levels trigger wakefulness, vigilance and hunger; reduced levels induce inactivity and somnolence.“Regulation of hunger and consciousness appear to be intimately tied to our metabolic state,” says Dr. Dev Sikder, an assistant professor in the Metabolic Signaling and Disease program at Sanford-Burnham’s Lake Nona campus . “Consistent with this theory, the cyclic waxing and waning of orexin levels appears to be perturbed in metabolic disorders such as type 2 diabetes, obesity and even cancer. These disorders are also a consequence of physical inactivity and sleep/wake disturbances, which are directly influenced by orexin. Indeed, several epidemiological studies have reported a correlation between lower orexin levels and a higher incidence of obesity and type 2 diabetes.”

Orexin agonists and antagonists are already in clinical trials for narcolepsy, insomnia, eating disorders and even addiction. Given that the hormone is detectable in plasma and the receptors are expressed in pancreatic and fat tissue, it is of immense interest to address the impact of orexin signaling in peripheral tissues.

At the cellular level, orexins augment the mitochondria’s ability to burn sugar. Disruption of orexin function in mice results in age-related insulin resistance and impaired glucose tolerance. Dr. Sikder is currently studying how deregulation and intentional abuse of the metabolism-sensitive feeding and sleep switch contribute to diabetes and obesity.

Orexin and Cancer

There is a growing realization that nutrient availability, nutrient signaling pathways and hormone signaling pathways are tightly linked to cell proliferation and survival. The orexin-stimulated pathway increases the metabolic capacity of cells and in doing so appears to increase cancer potential. For example, orexin mutes VHL expression and loss of VHL function is known to promote hemangioblastoma and clear cell renal carcinoma. Orexin stabilizes HIF1-alpha, a protein known to promote cancer. The orexin metabolic boost by itself gives aggressive cells the ability to “out-compete” their less aggressive cousins. So the question is: Could orexin signaling activate tumorigenesis? Preliminary investigations suggest that orexin signaling may play a critical role in the process that turns normal cells into cancerous cells. Efforts are underway to analyze the impact of orexin signaling in cancer.

Tags: Lake Nona, Metabolic Signaling, metabolism

Post a Comment Cancel reply

* All fields are required

CAPTCHA Image
Refresh Image

*

8 Comments

  1. Diana Lauhon says:
    March 4, 2013 at 12:34 pm

    The article mentions orexin agonist clincal trials for narcolepsy. I wasn’t aware of any. Could you please tell me of any and where they are available? Also, what would be the possible connection between treatment with Provigil for Narcolepsy and a sustained low blood sugar in the absence of any type of diabetes or hypoglycemia present?

    Reply
  2. Margaret Skoog RN says:
    January 8, 2011 at 11:56 am

    Read this post with extreme interest. Asking your advice: best endocrineologist in Sioux Falls/Sanford. Husband, 75, has been CPAP user x 5 yrs, hypopneas 46%, now on Nuvagil 250 for excessive daytime sleepiness. It’s helpinga lot! On 1/3 we enrolled in a study at McKennan/Sioux Falls that is comparing the genetic variations of insulin-like growth factor receptors in patients with dementia, Dr. Chakunta, 605-322-5737. Review of meds, med hx, Dr. Chakunta strongly suggested husband see endocrineologist to get re-tested for diabetes (never tops out of GTT but gets hypoglycemic with sugars in the 40s before end of test, not on any diabetic meds) and have current dose of synthroid (250 mcg) evaluated. Husband who has exhibited much forgetfullness, confusion, and ?depression passed two mental tests of alertness and orientation with only one tiny variation and was assurred he needed no meds at this time for Alzheimer’s. Has been assessed completely by Dr. Stys, on minimal meds for heart failure, no changes after assessment, no follow up needed. Truly believe the work you are doing is going to be revolutionary in the world of diabetes management. Absolutely, wonderfully amazing. God bless you in what you have discovered. I would appreciate a reply. Thank you so much for your time and consideration. Margaret Skoog RN 605-432-4385

    Reply
  3. gowtham says:
    November 25, 2010 at 7:36 am

    Respected sir,
    Sir, I want to ask you that ”Leptin ‘protein is also associated with our hunger and it’s binding to the receptor in brain triggers our apetite and as you mentioned above that level of Orexin hormone in blood influences cell metabolism and it is also associated with conversion of normal cell into cancareous cell. Do leptin protein play any role in this all matter as it has been found to be responsible for controlling apetite and it’s defiiency causes obesity.

    Reply
  4. Shailendra says:
    November 8, 2010 at 3:31 am

    Respected Sir,

    Sir, I want to ask you that ”Leptin ‘protein is also associated with our hunger and it’s binding to the receptor in brain triggers our apetite and as you mentioned above that level of Orexin hormone in blood influences cell metabolism and it is also associated with conversion of normal cell into cancareous cell. Do leptin protein play any role in this all matter as it has been found to be responsible for controlling apetite and it’s defiiency causes obesity.

    Reply

Search

Find more information

  • About Beaker
  • Contact us
  • Donate

Please take a quick survey

Which of these items describes you?

Select all that apply. (Question 1 of 5)

Categories

  • Basic Research
  • Cancer
    • Apoptosis & Cell Death Research
    • Signal Transduction
    • Tumor Development
    • Tumor Microenvironment
  • Children's Health
    • Genetic Diseases
    • Muscle Development & Regeneration
    • RNA Biology
  • Diabetes & Obesity
    • Cardiovascular Pathobiology
    • Metabolic Signaling & Disease
  • Drug Discovery
  • Events
  • Graduate School of Biomedical Sciences
  • Grants
  • Infectious & Inflammatory Diseases
    • Bioinformatics & Systems Biology
    • Infectious Diseases
    • Inflammatory Diseases
  • Nanomedicine
  • Neuroscience, Aging, & Stem Cells
    • Degenerative Diseases
    • Development & Aging
    • Stem Cells
  • Other
  • People
  • Sanford-Burnham Supporters
  • Translational Medicine

Search by Keyword

CCRA CIRM collaboration commitment communication community Daniel Kelly Erkki Ruoslahti Evan Snyder events Florida Hospital Fred Levine Genetic Disease Program Guy Salvesen Hudson Freeze John Reed Kristiina Vuori La Jolla Lake Nona Metabolic Signaling metabolism NIH Orlando personalized medicine Prebys Center press proteins Rare Diseases Rare disease symposium research publications Robert Wechsler-Reya Santa Barbara Sara Courtneidge Sheila Collins Stem Cells Steven Smith Stuart Lipton T. Denny Sanford technology Translational Research Institute tumor microenvironment Tumor Microenvironment Program Video Yu Yamaguchi Ze'ev Ronai

© Sanford-Burnham Medical Research Institute. All rights reserved.

Get Cloud PHP Hosting on CatN